Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group

Keyphrases

• Consensus Recommendations 100%
• On-site Monitoring 100%
• Lysosomal Acid Lipase 100%
• Collaborative Working 100%
• Healthcare 18%
• Hepatocytes 9%
• Functional mutation 9%
• Disease Progression 9%
• Cirrhosis 9%
• Macrophages 9%
• Autosomal Recessive 9%
• Evidence-based 9%
• Specialty Care 9%
• Premature Mortality 9%
• Vascular Disease 9%
• Cardiology 9%
• Disease-based 9%
• Cardiovascular System 9%
• Clinical Genetics 9%
• Liver Fibrosis 9%
• Triglycerides 9%
• Dyslipidemia 9%
• Clinical Spectrum 9%
• Systemic Disease 9%
• Systemic Involvement 9%
• Morbidity Mortality 9%
• Disease Manifestations 9%
• Hepatology 9%
• Intestine 9%
• Gastroenterology 9%
• Hepatic Steatosis 9%
• Treatment Status 9%
• Gastrointestinal System 9%
• Ultra-rare 9%
• Elevated Liver Enzymes 9%
• Vascular Endothelial 9%
• Hepatosplenomegaly 9%
• Clinical Pathology 9%
• Interdisciplinary Health Team 9%
• Cholesteryl Ester 9%
• Integrated Care Teams 9%
• Genetic Pathology 9%
• Endothelial System 9%
• Hepatic System 9%
• Clinical Lipidology 9%

Medicine and Dentistry

• Acid Lipase 100%
• Disease 27%
• Patient Monitoring 27%
• Triacylglycerol 9%
• Disease Exacerbation 9%
• Cardiovascular System 9%
• Dyslipidemia 9%
• Autosomal Recessive Disorder 9%
• Vascular Disease 9%
• Hepatocyte 9%
• Liver Cirrhosis 9%
• Premature Mortality 9%
• Macrophage 9%
• Cardiology 9%
• Liver Fibrosis 9%
• Systemic Disease 9%
• Hepatology 9%
• Gastroenterology 9%
• Fatty Liver 9%
• Intestine 9%
• Liver Enzyme 9%
• Cholesterol Ester 9%
• Clinical Genetics 9%
• Hepatosplenomegaly 9%
• Gastrointestinal System 9%
• Hepatic System 9%